Global Microphysiological System Market Growth (Status and Outlook) 2026-2032

October 2026 | 169 pages | ID: GFBC804D66F6EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Microphysiological System market size is predicted to grow from US$ 245 million in 2025 to US$ 726 million in 2032; it is expected to grow at a CAGR of 16.8% from 2026 to 2032.

Microphysiological Systems (MPS) are advanced in vitro models that use human-derived cells, tissues, or organoids together with technologies such as three-dimensional culture, microfluidics, extracellular matrices, dynamic perfusion, mechanical stimulation, and integrated sensing to reproduce key structural, functional, and physiological characteristics of human tissues or organs. MPS include Organ-on-Chip systems, multi-organ platforms, organoid-based MPS, and certain engineered 3D tissue models. These systems can simulate cell-cell interactions, tissue barriers, fluid shear stress, and inter-organ communication. They are mainly used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing, with the goal of improving the human relevance and predictive value of preclinical research.Microphysiological Systems (MPS) vary significantly in price depending on platform format, cell source, tissue model complexity, throughput, and the level of integration with perfusion, imaging, and automation. In 2025–2026, basic MPS chips or 3D culture consumables are generally priced at around US$50–1,000 per chip or plate, while complex human cell-based or organoid model kits typically range from US$500–5,000 per kit. Platforms equipped with pumping, perfusion, or culture-control functions generally cost about US$5,000–30,000 per system, while high-throughput automated MPS workstations may reach US$50,000–150,000 or more per system.

The upstream value chain mainly includes human primary cells, induced pluripotent stem cells, organoids, culture media, extracellular matrices, hydrogels, PDMS, COC/COP, glass, porous membranes, sensors, and microfluidic components. Midstream companies develop and integrate MPS chips, 3D tissue models, perfusion-control devices, and automated platforms. Downstream users mainly include pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, and regulatory agencies. MPS platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.

Market Drivers

Growing Regulatory Support for Non-Animal Testing Methods

Regulatory agencies are increasingly encouraging the use of New Approach Methodologies, including microphysiological systems, organ-on-chip platforms, organoids, and computational models. In April 2025, the FDA released a roadmap to reduce reliance on animal testing in preclinical safety studies and specifically highlighted human-based models such as organ-on-chip systems. This regulatory shift is strengthening demand for validated MPS platforms in pharmaceutical safety and efficacy assessment.

Increasing Demand for Human-Relevant Preclinical Models

Traditional 2D cell cultures often fail to reproduce complex tissue architecture and physiological functions, while animal models may show species-specific differences in metabolism, immune response, and drug toxicity. MPS platforms recreate important biochemical, mechanical, and physiological conditions using human-derived cells and tissues, improving their potential to predict human drug responses and supporting broader adoption in drug discovery and development.

Rising Pharmaceutical R&D Efficiency Requirements

Pharmaceutical and biotechnology companies are seeking technologies that can identify ineffective or toxic candidates earlier in development. MPS platforms can support drug screening, ADME/DMPK studies, toxicity testing, disease modeling, and efficacy assessment using physiologically relevant human models. NIH continues to support tissue-chip programs designed to improve predictions of drug safety and toxicity in humans, strengthening the technology’s position within preclinical research workflows.

Market Restraints

High Platform and Experimental Costs

MPS experiments may require specialized chips or culture plates, human primary or stem-cell-derived cells, extracellular matrices, sensors, perfusion equipment, imaging systems, and dedicated analytical workflows. These requirements make MPS studies more expensive and operationally demanding than conventional 2D cell culture, particularly for small biotechnology companies and academic laboratories with limited budgets.

Insufficient Standardization and Reproducibility

Commercial MPS platforms differ substantially in materials, channel architecture, cell sources, extracellular matrices, flow conditions, assay endpoints, and operating protocols. This heterogeneity can create challenges in comparing results between laboratories and platforms. Wider regulatory and pharmaceutical adoption therefore requires improved quality control, reproducibility, standardized reporting, and fit-for-purpose validation criteria. OECD guidance increasingly emphasizes quality-management and fit-for-purpose considerations for MPS-related regulatory data.

Dependence on High-Quality Human Cells and Biological Materials

MPS performance is highly dependent on primary human cells, induced pluripotent stem-cell-derived cells, organoids, culture media, and extracellular matrices. Variability between donors and production batches, limited availability of certain mature cell types, and difficulties maintaining stable phenotypes during long-term culture can reduce reproducibility and complicate large-scale deployment. Market Opportunities

Expansion into Regulatory Toxicology and Safety Assessment

One of the largest opportunities for MPS is its transition from an academic research tool to a qualified platform for regulatory and industrial safety assessment. Liver, cardiac, kidney, lung, immune, and barrier models have particular potential for evaluating organ-specific toxicity. FDA and NIH collaboration on New Approach Methodologies is creating a more favorable environment for validated human-based models to enter formal drug-development workflows.

Development of High-Throughput and Automated MPS Platforms

Integration with multi-well formats, automated liquid handling, high-content imaging, biosensors, and data-analysis software can substantially increase MPS throughput and reproducibility. The industry is moving beyond manually operated individual chips toward scalable platforms capable of running dozens or hundreds of tissue models simultaneously, making MPS more compatible with pharmaceutical screening workflows and increasing recurring demand for consumables.

Integration with Organoids, iPSC Technology and AI

Combining MPS with patient-derived organoids, induced pluripotent stem cells, gene editing, and artificial intelligence can enable more disease-specific and patient-specific models. Such platforms could support precision medicine, patient stratification, rare-disease research, and prediction of individual drug responses. Multi-organ MPS further creates opportunities for studying systemic pharmacology, PK/PD relationships, metabolism, and organ-to-organ interactions.

Market Challenges

Balancing Physiological Complexity with Throughput and Scalability

Increasing biological realism often requires multiple cell types, vascular interfaces, extracellular matrices, mechanical stimulation, dynamic perfusion, and real-time sensing. However, greater complexity usually increases operating difficulty, cost, variability, and assay duration. Achieving sufficient physiological relevance while maintaining reproducibility, throughput, automation, and commercial scalability remains a fundamental technical challenge.

Extensive Validation Required for Regulatory Acceptance

Regulatory interest in MPS is increasing, but formal use in decision-making requires robust evidence demonstrating reproducibility, reliability, defined applicability domains, and correlation with human clinical outcomes. Cross-laboratory studies, reference-compound testing, standardized protocols, and comparison against existing methods remain necessary before individual MPS models can achieve broad regulatory acceptance.

Fragmentation of Technologies and Commercial Platforms

The MPS market includes organ-on-chip systems, organoid-based models, engineered 3D tissues, membrane and membrane-free platforms, passive and pump-driven systems, and single- and multi-organ configurations. No single architecture has emerged as the universal industry standard. This fragmentation increases platform-selection risks for pharmaceutical companies and creates significant R&D and commercialization challenges for MPS suppliers.

Report Scope

LPI (LP Information)' newest research report, the “Microphysiological System Industry Forecast” looks at past sales and reviews total world Microphysiological System sales in 2025, providing a comprehensive analysis by region and market sector of projected Microphysiological System sales for 2026 through 2032. With Microphysiological System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microphysiological System industry.

This Insight Report provides a comprehensive analysis of the global Microphysiological System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microphysiological System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microphysiological System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microphysiological System and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microphysiological System.

This report presents a comprehensive overview, market shares, and growth opportunities of Microphysiological System market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Liver MPS
  • Lung MPS
  • Cardiac MPS
  • Kidney MPS
  • Gastrointestinal MPS
  • Neural/Brain MPS
  • Other

Segmentation by System Integration:

  • Single-organ MPS
  • Multi-organ MPS

Segmentation by Platform Type:

  • Organ-on-Chip Systems
  • Organoid-based MPS
  • 3D Engineered Tissue MPS
  • Others

Segmentation by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Emulate
  • MIMETAS
  • TissUse
  • CN Bio Innovations
  • AIM Biotech
  • AlveoliX
  • Beonchip
  • React4life
  • InSphero
  • NETRI
  • SynVivo
  • BiomimX
  • Dynamic42
  • Kirkstall
  • Cherry Biotech
  • Micronit
  • Cellbox Labs
  • REVIVO BioSystems
  • MesoBioTech
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
  • Altis Biosystems
  • 28bio
  • Bi/ond
  • Ananda Devices
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microphysiological System Market Size (2021-2032)
  2.1.2 Microphysiological System Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Microphysiological System by Country/Region (2021, 2025 & 2032)
2.2 Microphysiological System Segment by Type
  2.2.1 Liver MPS
  2.2.2 Lung MPS
  2.2.3 Cardiac MPS
  2.2.4 Kidney MPS
  2.2.5 Gastrointestinal MPS
  2.2.6 Neural/Brain MPS
  2.2.7 Other
  2.2.8 Microphysiological System Market Size by Type
    2.2.8.1 Microphysiological System Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.8.2 Global Microphysiological System Market Size Market Share by Type (2021-2026)
2.3 Microphysiological System Segment by System Integration
  2.3.1 Single-organ MPS
  2.3.2 Multi-organ MPS
  2.3.3 Microphysiological System Market Size by System Integration
    2.3.3.1 Microphysiological System Market Size CAGR by System Integration (2021 VS 2025 VS 2032)
    2.3.3.2 Global Microphysiological System Market Size Market Share by System Integration (2021-2026)
2.4 Microphysiological System Segment by Platform Type
  2.4.1 Organ-on-Chip Systems
  2.4.2 Organoid-based MPS
  2.4.3 3D Engineered Tissue MPS
  2.4.4 Others
  2.4.5 Microphysiological System Market Size by Platform Type
    2.4.5.1 Microphysiological System Market Size CAGR by Platform Type (2021 VS 2025 VS 2032)
    2.4.5.2 Global Microphysiological System Market Size Market Share by Platform Type (2021-2026)
2.5 Microphysiological System Segment by End User
  2.5.1 Pharmaceutical & Biotechnology Companies
  2.5.2 Academic & Research Institutes
  2.5.3 Others
  2.5.4 Microphysiological System Market Size by End User
    2.5.4.1 Microphysiological System Market Size CAGR by End User (2021 VS 2025 VS 2032)
    2.5.4.2 Global Microphysiological System Market Size Market Share by End User (2021-2026)

3 MICROPHYSIOLOGICAL SYSTEM MARKET SIZE BY PLAYER

3.1 Microphysiological System Market Size Market Share by Player
  3.1.1 Global Microphysiological System Revenue by Player (2021-2026)
  3.1.2 Global Microphysiological System Revenue Market Share by Player (2021-2026)
3.2 Global Microphysiological System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MICROPHYSIOLOGICAL SYSTEM BY REGION

4.1 Microphysiological System Market Size by Region (2021-2026)
4.2 Global Microphysiological System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Microphysiological System Market Size Growth (2021-2026)
4.4 APAC Microphysiological System Market Size Growth (2021-2026)
4.5 Europe Microphysiological System Market Size Growth (2021-2026)
4.6 Middle East & Africa Microphysiological System Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Microphysiological System Market Size by Country (2021-2026)
5.2 Americas Microphysiological System Market Size by Type (2021-2026)
5.3 Americas Microphysiological System Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microphysiological System Market Size by Region (2021-2026)
6.2 APAC Microphysiological System Market Size by Type (2021-2026)
6.3 APAC Microphysiological System Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Microphysiological System Market Size by Country (2021-2026)
7.2 Europe Microphysiological System Market Size by Type (2021-2026)
7.3 Europe Microphysiological System Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microphysiological System by Region (2021-2026)
8.2 Middle East & Africa Microphysiological System Market Size by Type (2021-2026)
8.3 Middle East & Africa Microphysiological System Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MICROPHYSIOLOGICAL SYSTEM MARKET FORECAST

10.1 Global Microphysiological System Forecast by Region (2027-2032)
  10.1.1 Global Microphysiological System Forecast by Region (2027-2032)
  10.1.2 Americas Microphysiological System Forecast
  10.1.3 APAC Microphysiological System Forecast
  10.1.4 Europe Microphysiological System Forecast
  10.1.5 Middle East & Africa Microphysiological System Forecast
10.2 Americas Microphysiological System Forecast by Country (2027-2032)
  10.2.1 United States Market Microphysiological System Forecast
  10.2.2 Canada Market Microphysiological System Forecast
  10.2.3 Mexico Market Microphysiological System Forecast
  10.2.4 Brazil Market Microphysiological System Forecast
10.3 APAC Microphysiological System Forecast by Region (2027-2032)
  10.3.1 China Microphysiological System Market Forecast
  10.3.2 Japan Market Microphysiological System Forecast
  10.3.3 Korea Market Microphysiological System Forecast
  10.3.4 Southeast Asia Market Microphysiological System Forecast
  10.3.5 India Market Microphysiological System Forecast
  10.3.6 Australia Market Microphysiological System Forecast
10.4 Europe Microphysiological System Forecast by Country (2027-2032)
  10.4.1 Germany Market Microphysiological System Forecast
  10.4.2 France Market Microphysiological System Forecast
  10.4.3 UK Market Microphysiological System Forecast
  10.4.4 Italy Market Microphysiological System Forecast
  10.4.5 Russia Market Microphysiological System Forecast
10.5 Middle East & Africa Microphysiological System Forecast by Region (2027-2032)
  10.5.1 Egypt Market Microphysiological System Forecast
  10.5.2 South Africa Market Microphysiological System Forecast
  10.5.3 Israel Market Microphysiological System Forecast
  10.5.4 Turkey Market Microphysiological System Forecast
10.6 Global Microphysiological System Forecast by Type (2027-2032)
10.7 Global Microphysiological System Forecast by End User (2027-2032)
  10.7.1 GCC Countries Market Microphysiological System Forecast

11 KEY PLAYERS ANALYSIS

11.1 Emulate
  11.1.1 Emulate Company Information
  11.1.2 Emulate Microphysiological System Product Offered
  11.1.3 Emulate Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Emulate Main Business Overview
  11.1.5 Emulate Latest Developments
11.2 MIMETAS
  11.2.1 MIMETAS Company Information
  11.2.2 MIMETAS Microphysiological System Product Offered
  11.2.3 MIMETAS Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 MIMETAS Main Business Overview
  11.2.5 MIMETAS Latest Developments
11.3 TissUse
  11.3.1 TissUse Company Information
  11.3.2 TissUse Microphysiological System Product Offered
  11.3.3 TissUse Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 TissUse Main Business Overview
  11.3.5 TissUse Latest Developments
11.4 CN Bio Innovations
  11.4.1 CN Bio Innovations Company Information
  11.4.2 CN Bio Innovations Microphysiological System Product Offered
  11.4.3 CN Bio Innovations Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 CN Bio Innovations Main Business Overview
  11.4.5 CN Bio Innovations Latest Developments
11.5 AIM Biotech
  11.5.1 AIM Biotech Company Information
  11.5.2 AIM Biotech Microphysiological System Product Offered
  11.5.3 AIM Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 AIM Biotech Main Business Overview
  11.5.5 AIM Biotech Latest Developments
11.6 AlveoliX
  11.6.1 AlveoliX Company Information
  11.6.2 AlveoliX Microphysiological System Product Offered
  11.6.3 AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 AlveoliX Main Business Overview
  11.6.5 AlveoliX Latest Developments
11.7 Beonchip
  11.7.1 Beonchip Company Information
  11.7.2 Beonchip Microphysiological System Product Offered
  11.7.3 Beonchip Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Beonchip Main Business Overview
  11.7.5 Beonchip Latest Developments
11.8 React4life
  11.8.1 React4life Company Information
  11.8.2 React4life Microphysiological System Product Offered
  11.8.3 React4life Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 React4life Main Business Overview
  11.8.5 React4life Latest Developments
11.9 InSphero
  11.9.1 InSphero Company Information
  11.9.2 InSphero Microphysiological System Product Offered
  11.9.3 InSphero Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 InSphero Main Business Overview
  11.9.5 InSphero Latest Developments
11.10 NETRI
  11.10.1 NETRI Company Information
  11.10.2 NETRI Microphysiological System Product Offered
  11.10.3 NETRI Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 NETRI Main Business Overview
  11.10.5 NETRI Latest Developments
11.11 SynVivo
  11.11.1 SynVivo Company Information
  11.11.2 SynVivo Microphysiological System Product Offered
  11.11.3 SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 SynVivo Main Business Overview
  11.11.5 SynVivo Latest Developments
11.12 BiomimX
  11.12.1 BiomimX Company Information
  11.12.2 BiomimX Microphysiological System Product Offered
  11.12.3 BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 BiomimX Main Business Overview
  11.12.5 BiomimX Latest Developments
11.13 Dynamic42
  11.13.1 Dynamic42 Company Information
  11.13.2 Dynamic42 Microphysiological System Product Offered
  11.13.3 Dynamic42 Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Dynamic42 Main Business Overview
  11.13.5 Dynamic42 Latest Developments
11.14 Kirkstall
  11.14.1 Kirkstall Company Information
  11.14.2 Kirkstall Microphysiological System Product Offered
  11.14.3 Kirkstall Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Kirkstall Main Business Overview
  11.14.5 Kirkstall Latest Developments
11.15 Cherry Biotech
  11.15.1 Cherry Biotech Company Information
  11.15.2 Cherry Biotech Microphysiological System Product Offered
  11.15.3 Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Cherry Biotech Main Business Overview
  11.15.5 Cherry Biotech Latest Developments
11.16 Micronit
  11.16.1 Micronit Company Information
  11.16.2 Micronit Microphysiological System Product Offered
  11.16.3 Micronit Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Micronit Main Business Overview
  11.16.5 Micronit Latest Developments
11.17 Cellbox Labs
  11.17.1 Cellbox Labs Company Information
  11.17.2 Cellbox Labs Microphysiological System Product Offered
  11.17.3 Cellbox Labs Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Cellbox Labs Main Business Overview
  11.17.5 Cellbox Labs Latest Developments
11.18 REVIVO BioSystems
  11.18.1 REVIVO BioSystems Company Information
  11.18.2 REVIVO BioSystems Microphysiological System Product Offered
  11.18.3 REVIVO BioSystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 REVIVO BioSystems Main Business Overview
  11.18.5 REVIVO BioSystems Latest Developments
11.19 MesoBioTech
  11.19.1 MesoBioTech Company Information
  11.19.2 MesoBioTech Microphysiological System Product Offered
  11.19.3 MesoBioTech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 MesoBioTech Main Business Overview
  11.19.5 MesoBioTech Latest Developments
11.20 Beijing Daxiang Biotech
  11.20.1 Beijing Daxiang Biotech Company Information
  11.20.2 Beijing Daxiang Biotech Microphysiological System Product Offered
  11.20.3 Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 Beijing Daxiang Biotech Main Business Overview
  11.20.5 Beijing Daxiang Biotech Latest Developments
11.21 AVATARGET
  11.21.1 AVATARGET Company Information
  11.21.2 AVATARGET Microphysiological System Product Offered
  11.21.3 AVATARGET Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 AVATARGET Main Business Overview
  11.21.5 AVATARGET Latest Developments
11.22 Suzhou Jiyan Biopharmaceutical
  11.22.1 Suzhou Jiyan Biopharmaceutical Company Information
  11.22.2 Suzhou Jiyan Biopharmaceutical Microphysiological System Product Offered
  11.22.3 Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.22.4 Suzhou Jiyan Biopharmaceutical Main Business Overview
  11.22.5 Suzhou Jiyan Biopharmaceutical Latest Developments
11.23 Altis Biosystems
  11.23.1 Altis Biosystems Company Information
  11.23.2 Altis Biosystems Microphysiological System Product Offered
  11.23.3 Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.23.4 Altis Biosystems Main Business Overview
  11.23.5 Altis Biosystems Latest Developments
11.24 28bio
  11.24.1 28bio Company Information
  11.24.2 28bio Microphysiological System Product Offered
  11.24.3 28bio Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.24.4 28bio Main Business Overview
  11.24.5 28bio Latest Developments
11.25 Bi/ond
  11.25.1 Bi/ond Company Information
  11.25.2 Bi/ond Microphysiological System Product Offered
  11.25.3 Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.25.4 Bi/ond Main Business Overview
  11.25.5 Bi/ond Latest Developments
11.26 Ananda Devices
  11.26.1 Ananda Devices Company Information
  11.26.2 Ananda Devices Microphysiological System Product Offered
  11.26.3 Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2021-2026)
  11.26.4 Ananda Devices Main Business Overview
  11.26.5 Ananda Devices Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Microphysiological System Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Microphysiological System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liver MPS
Table 4. Major Players of Lung MPS
Table 5. Major Players of Cardiac MPS
Table 6. Major Players of Kidney MPS
Table 7. Major Players of Gastrointestinal MPS
Table 8. Major Players of Neural/Brain MPS
Table 9. Major Players of Other
Table 10. Microphysiological System Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Microphysiological System Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Microphysiological System Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Single-organ MPS
Table 14. Major Players of Multi-organ MPS
Table 15. Microphysiological System Market Size CAGR by System Integration (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Microphysiological System Market Size by System Integration (2021-2026) & ($ millions)
Table 17. Global Microphysiological System Market Size Market Share by System Integration (2021-2026)
Table 18. Major Players of Organ-on-Chip Systems
Table 19. Major Players of Organoid-based MPS
Table 20. Major Players of 3D Engineered Tissue MPS
Table 21. Major Players of Others
Table 22. Microphysiological System Market Size CAGR by Platform Type (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Microphysiological System Market Size by Platform Type (2021-2026) & ($ millions)
Table 24. Global Microphysiological System Market Size Market Share by Platform Type (2021-2026)
Table 25. Microphysiological System Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Microphysiological System Market Size by End User (2021-2026) & ($ millions)
Table 27. Global Microphysiological System Market Size Market Share by End User (2021-2026)
Table 28. Global Microphysiological System Revenue by Player (2021-2026) & ($ millions)
Table 29. Global Microphysiological System Revenue Market Share by Player (2021-2026)
Table 30. Microphysiological System Key Players Head office and Products Offered
Table 31. Microphysiological System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Mergers & Acquisitions, Expansion
Table 34. Global Microphysiological System Market Size by Region (2021-2026) & ($ millions)
Table 35. Global Microphysiological System Market Size Market Share by Region (2021-2026)
Table 36. Global Microphysiological System Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Microphysiological System Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Microphysiological System Market Size by Country (2021-2026) & ($ millions)
Table 39. Americas Microphysiological System Market Size Market Share by Country (2021-2026)
Table 40. Americas Microphysiological System Market Size by Type (2021-2026) & ($ millions)
Table 41. Americas Microphysiological System Market Size Market Share by Type (2021-2026)
Table 42. Americas Microphysiological System Market Size by End User (2021-2026) & ($ millions)
Table 43. Americas Microphysiological System Market Size Market Share by End User (2021-2026)
Table 44. APAC Microphysiological System Market Size by Region (2021-2026) & ($ millions)
Table 45. APAC Microphysiological System Market Size Market Share by Region (2021-2026)
Table 46. APAC Microphysiological System Market Size by Type (2021-2026) & ($ millions)
Table 47. APAC Microphysiological System Market Size by End User (2021-2026) & ($ millions)
Table 48. Europe Microphysiological System Market Size by Country (2021-2026) & ($ millions)
Table 49. Europe Microphysiological System Market Size Market Share by Country (2021-2026)
Table 50. Europe Microphysiological System Market Size by Type (2021-2026) & ($ millions)
Table 51. Europe Microphysiological System Market Size by End User (2021-2026) & ($ millions)
Table 52. Middle East & Africa Microphysiological System Market Size by Region (2021-2026) & ($ millions)
Table 53. Middle East & Africa Microphysiological System Market Size by Type (2021-2026) & ($ millions)
Table 54. Middle East & Africa Microphysiological System Market Size by End User (2021-2026) & ($ millions)
Table 55. Key Market Drivers & Growth Opportunities of Microphysiological System
Table 56. Key Market Challenges & Risks of Microphysiological System
Table 57. Key Industry Trends of Microphysiological System
Table 58. Global Microphysiological System Market Size Forecast by Region (2027-2032) & ($ millions)
Table 59. Global Microphysiological System Market Size Market Share Forecast by Region (2027-2032)
Table 60. Global Microphysiological System Market Size Forecast by Type (2027-2032) & ($ millions)
Table 61. Global Microphysiological System Market Size Forecast by End User (2027-2032) & ($ millions)
Table 62. Emulate Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 63. Emulate Microphysiological System Product Offered
Table 64. Emulate Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Emulate Main Business
Table 66. Emulate Latest Developments
Table 67. MIMETAS Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 68. MIMETAS Microphysiological System Product Offered
Table 69. MIMETAS Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. MIMETAS Main Business
Table 71. MIMETAS Latest Developments
Table 72. TissUse Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 73. TissUse Microphysiological System Product Offered
Table 74. TissUse Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. TissUse Main Business
Table 76. TissUse Latest Developments
Table 77. CN Bio Innovations Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 78. CN Bio Innovations Microphysiological System Product Offered
Table 79. CN Bio Innovations Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. CN Bio Innovations Main Business
Table 81. CN Bio Innovations Latest Developments
Table 82. AIM Biotech Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 83. AIM Biotech Microphysiological System Product Offered
Table 84. AIM Biotech Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. AIM Biotech Main Business
Table 86. AIM Biotech Latest Developments
Table 87. AlveoliX Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 88. AlveoliX Microphysiological System Product Offered
Table 89. AlveoliX Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. AlveoliX Main Business
Table 91. AlveoliX Latest Developments
Table 92. Beonchip Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 93. Beonchip Microphysiological System Product Offered
Table 94. Beonchip Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Beonchip Main Business
Table 96. Beonchip Latest Developments
Table 97. React4life Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 98. React4life Microphysiological System Product Offered
Table 99. React4life Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. React4life Main Business
Table 101. React4life Latest Developments
Table 102. InSphero Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 103. InSphero Microphysiological System Product Offered
Table 104. InSphero Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. InSphero Main Business
Table 106. InSphero Latest Developments
Table 107. NETRI Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 108. NETRI Microphysiological System Product Offered
Table 109. NETRI Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. NETRI Main Business
Table 111. NETRI Latest Developments
Table 112. SynVivo Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 113. SynVivo Microphysiological System Product Offered
Table 114. SynVivo Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. SynVivo Main Business
Table 116. SynVivo Latest Developments
Table 117. BiomimX Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 118. BiomimX Microphysiological System Product Offered
Table 119. BiomimX Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. BiomimX Main Business
Table 121. BiomimX Latest Developments
Table 122. Dynamic42 Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 123. Dynamic42 Microphysiological System Product Offered
Table 124. Dynamic42 Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Dynamic42 Main Business
Table 126. Dynamic42 Latest Developments
Table 127. Kirkstall Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 128. Kirkstall Microphysiological System Product Offered
Table 129. Kirkstall Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Kirkstall Main Business
Table 131. Kirkstall Latest Developments
Table 132. Cherry Biotech Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 133. Cherry Biotech Microphysiological System Product Offered
Table 134. Cherry Biotech Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Cherry Biotech Main Business
Table 136. Cherry Biotech Latest Developments
Table 137. Micronit Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 138. Micronit Microphysiological System Product Offered
Table 139. Micronit Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Micronit Main Business
Table 141. Micronit Latest Developments
Table 142. Cellbox Labs Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 143. Cellbox Labs Microphysiological System Product Offered
Table 144. Cellbox Labs Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Cellbox Labs Main Business
Table 146. Cellbox Labs Latest Developments
Table 147. REVIVO BioSystems Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 148. REVIVO BioSystems Microphysiological System Product Offered
Table 149. REVIVO BioSystems Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. REVIVO BioSystems Main Business
Table 151. REVIVO BioSystems Latest Developments
Table 152. MesoBioTech Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 153. MesoBioTech Microphysiological System Product Offered
Table 154. MesoBioTech Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. MesoBioTech Main Business
Table 156. MesoBioTech Latest Developments
Table 157. Beijing Daxiang Biotech Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 158. Beijing Daxiang Biotech Microphysiological System Product Offered
Table 159. Beijing Daxiang Biotech Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Beijing Daxiang Biotech Main Business
Table 161. Beijing Daxiang Biotech Latest Developments
Table 162. AVATARGET Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 163. AVATARGET Microphysiological System Product Offered
Table 164. AVATARGET Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. AVATARGET Main Business
Table 166. AVATARGET Latest Developments
Table 167. Suzhou Jiyan Biopharmaceutical Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 168. Suzhou Jiyan Biopharmaceutical Microphysiological System Product Offered
Table 169. Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Suzhou Jiyan Biopharmaceutical Main Business
Table 171. Suzhou Jiyan Biopharmaceutical Latest Developments
Table 172. Altis Biosystems Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 173. Altis Biosystems Microphysiological System Product Offered
Table 174. Altis Biosystems Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Altis Biosystems Main Business
Table 176. Altis Biosystems Latest Developments
Table 177. 28bio Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 178. 28bio Microphysiological System Product Offered
Table 179. 28bio Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. 28bio Main Business
Table 181. 28bio Latest Developments
Table 182. Bi/ond Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 183. Bi/ond Microphysiological System Product Offered
Table 184. Bi/ond Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Bi/ond Main Business
Table 186. Bi/ond Latest Developments
Table 187. Ananda Devices Details, Company Type, Microphysiological System Area Served and Its Competitors
Table 188. Ananda Devices Microphysiological System Product Offered
Table 189. Ananda Devices Microphysiological System Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. Ananda Devices Main Business
Table 191. Ananda Devices Latest Developments

LIST OF FIGURES

Figure 1. Microphysiological System Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microphysiological System Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Microphysiological System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Microphysiological System Sales Market Share by Country/Region (2025)
Figure 8. Microphysiological System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Microphysiological System Market Size Market Share by Type in 2025
Figure 10. Global Microphysiological System Market Size Market Share by System Integration in 2025
Figure 11. Global Microphysiological System Market Size Market Share by Platform Type in 2025
Figure 12. Microphysiological System in Pharmaceutical & Biotechnology Companies
Figure 13. Global Microphysiological System Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Microphysiological System in Academic & Research Institutes
Figure 15. Global Microphysiological System Market: Academic & Research Institutes (2021-2026) & ($ millions)
Figure 16. Microphysiological System in Others
Figure 17. Global Microphysiological System Market: Others (2021-2026) & ($ millions)
Figure 18. Global Microphysiological System Market Size Market Share by End User in 2025
Figure 19. Global Microphysiological System Revenue Market Share by Player in 2025
Figure 20. Global Microphysiological System Market Size Market Share by Region (2021-2026)
Figure 21. Americas Microphysiological System Market Size 2021-2026 ($ millions)
Figure 22. APAC Microphysiological System Market Size 2021-2026 ($ millions)
Figure 23. Europe Microphysiological System Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Microphysiological System Market Size 2021-2026 ($ millions)
Figure 25. Americas Microphysiological System Value Market Share by Country in 2025
Figure 26. United States Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Microphysiological System Market Size Market Share by Region in 2025
Figure 31. APAC Microphysiological System Market Size Market Share by Type (2021-2026)
Figure 32. APAC Microphysiological System Market Size Market Share by End User (2021-2026)
Figure 33. China Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 37. India Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Microphysiological System Market Size Market Share by Country in 2025
Figure 40. Europe Microphysiological System Market Size Market Share by Type (2021-2026)
Figure 41. Europe Microphysiological System Market Size Market Share by End User (2021-2026)
Figure 42. Germany Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 43. France Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Microphysiological System Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Microphysiological System Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Microphysiological System Market Size Market Share by End User (2021-2026)
Figure 50. Egypt Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Microphysiological System Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Microphysiological System Market Size 2027-2032 ($ millions)
Figure 56. APAC Microphysiological System Market Size 2027-2032 ($ millions)
Figure 57. Europe Microphysiological System Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Microphysiological System Market Size 2027-2032 ($ millions)
Figure 59. United States Microphysiological System Market Size 2027-2032 ($ millions)
Figure 60. Canada Microphysiological System Market Size 2027-2032 ($ millions)
Figure 61. Mexico Microphysiological System Market Size 2027-2032 ($ millions)
Figure 62. Brazil Microphysiological System Market Size 2027-2032 ($ millions)
Figure 63. China Microphysiological System Market Size 2027-2032 ($ millions)
Figure 64. Japan Microphysiological System Market Size 2027-2032 ($ millions)
Figure 65. Korea Microphysiological System Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Microphysiological System Market Size 2027-2032 ($ millions)
Figure 67. India Microphysiological System Market Size 2027-2032 ($ millions)
Figure 68. Australia Microphysiological System Market Size 2027-2032 ($ millions)
Figure 69. Germany Microphysiological System Market Size 2027-2032 ($ millions)
Figure 70. France Microphysiological System Market Size 2027-2032 ($ millions)
Figure 71. UK Microphysiological System Market Size 2027-2032 ($ millions)
Figure 72. Italy Microphysiological System Market Size 2027-2032 ($ millions)
Figure 73. Russia Microphysiological System Market Size 2027-2032 ($ millions)
Figure 74. Egypt Microphysiological System Market Size 2027-2032 ($ millions)
Figure 75. South Africa Microphysiological System Market Size 2027-2032 ($ millions)
Figure 76. Israel Microphysiological System Market Size 2027-2032 ($ millions)
Figure 77. Turkey Microphysiological System Market Size 2027-2032 ($ millions)
Figure 78. Global Microphysiological System Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Microphysiological System Market Size Market Share Forecast by End User (2027-2032)
Figure 80. GCC Countries Microphysiological System Market Size 2027-2032 ($ millions)